Dr. Ehete Gebeyehu Bahiru, MD

Dr. Bahiru practices at Eisenhower Health in Rancho Mirage, California, part of Eisenhower Medical Center.

Dr. Bahiru's NPI, 1306189253, was assigned on March 28, 2013. Dr. Bahiru graduated from Stanford University School Of Medicine in 2013. Dr. Bahiru holds California license A148087.

Dr. Bahiru's primary practice is Eisenhower Health, at 39-000 Bob Hope Drive, Rancho Mirage, CA 92270 in Riverside County. The practice phone is (760) 340-3911. Dr. Bahiru also practices at Eisenhower Medical Center, 39000 Bob Hope Dr, Rancho Mirage, CA 92270.

Dr. Bahiru's primary practice is Eisenhower Health in Rancho Mirage, California, part of Eisenhower Medical Center. Dr. Bahiru is also affiliated with Desert Regional Medical Center. The medical group on file is Eisenhower Health. Dmand AI also links Dr. Bahiru to 2 more hospitals, 1 breast imaging center, 1 clinical lab and 1 dialysis center, each named with a free account. Dr. Bahiru's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bahiru practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Bahiru's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Bahiru is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Bahiru's licenses on file in 4 states: California, Washington, Oregon and Illinois.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiomyopathy, chronic hypertension, coronary artery disease, heart failure, heart valve disorders and high cholesterol among the conditions Dr. Bahiru treats.

CMS data shows 5,230 Medicare services from Dr. Bahiru across 36 procedure codes in 2024, for 906 Medicare patients. Medicare paid $221,734 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 906 Medicare patients who saw Dr. Bahiru in 2024. The largest group is 75 to 84, with 380 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bahiru's median patient age at 76, with 59% women.

In 2024, Dr. Bahiru wrote 3,476 Medicare Part D claims for 491 patients. 89% of them were for generic drugs. CMS names the drug for 3,295 of them, across 40 drugs with 11 or more claims each, at $471,627 in total drug cost. In 2023, CMS named 543 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Bahiru for performance year 2024, reported as part of a group. Dr. Bahiru accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bahiru as offering telehealth.

CMS Open Payments shows 35 general payments to Dr. Bahiru from 5 drug and device companies from 2018 to 2025. Travel and lodging make up the largest share, 71% of the total. Abbott Laboratories paid the most, $4,649.

Dr. Bahiru graduated from Stanford University School Of Medicine in 2013.

Dr. Bahiru is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.